Radius Health (RDUS) Misses Q4 EPS by 15c

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($1.59), $0.15 worse than the analyst estimate of ($1.44). Product revenue for the quarter came in at $7.66 million versus the consensus estimate of $7.03 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Webull Corp (BULL) Tops Q2 EPS by 1c
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts